After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations. According to a recent study by Tufts Center for the Study of Drug Development, the cost to develop one new drug is $2.6 billion, which means that companies can’t risk a failed launch. So how can life sciences companies overcome traditional product launch challenges to ensure their drugs reach patients and have a real impact?
Watch this webinar to learn how companies can use tailored analytics to support teams and uncover actionable insights throughout a product launch. You’ll also walk away with an understanding of how REVO Launch Analytics can help identify missed opportunities, prioritize key performance drivers, break silos and enable cross-functional collaboration.
Watch the webinar to learn about:
- The challenges that product and brand managers face while preparing for a launch and how to tackle them.
- Success stories of pharma companies that leveraged data and analytics both pre- and post – launch.
- How utilizing the power of ZS’s REVO Launch Analytics platform can ensure product launch success by setting up an agile, actionable, and cross-functional capability.